Boothbay Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,127
Closed -$302K 2377
2025
Q4
$302K Sell
12,127
-42,063
-78% -$1.06M ﹤0.01% 1425
2025
Q3
$1.38M Sell
54,190
-32,822
-38% -$810K 0.02% 703
2025
Q2
$2.11M Buy
+87,012
New +$2.03M 0.04% 490
2025
Q1
Sell
-50,336
Closed -$1.34M 1692
2024
Q4
$1.34M Buy
+50,336
New +$1.37M 0.03% 555
2024
Q3
Sell
-68,856
Closed -$1.93M 1848
2024
Q2
$1.93M Buy
+68,856
New +$1.9M 0.05% 513
2023
Q2
Sell
-148,262
Closed -$6.05M 2184
2023
Q1
$6.05M Buy
+148,262
New +$6.4M 0.12% 199
2022
Q4
Sell
-6,648
Closed -$319K 2351
2022
Q3
$291K Sell
6,648
-4,697
-41% -$228K 0.01% 1560
2022
Q2
$595K Buy
11,345
+458
+4% +$23.3K 0.02% 1090
2022
Q1
$564K Sell
10,887
-1,214,516
-99% -$63M 0.01% 1229
2021
Q4
$72.4M Buy
+1,225,403
New +$60.7M 1.7% 5
2021
Q1
Sell
-7,816
Closed -$288K 1730
2020
Q4
$288K Buy
+7,816
New +$287K 0.01% 967
2017
Q2
Sell
-14,096
Closed -$458K 801
2017
Q1
$458K Buy
14,096
+3,834
+37% +$121K 0.09% 278
2016
Q4
$1.06K Sell
10,262
-312
-3% -$9.53K 0.24% 78
2016
Q3
$340K Buy
10,574
+2,098
+25% +$70.2K 0.07% 340
2016
Q2
$283K Sell
8,476
-10,995
-56% -$351K 0.11% 265
2016
Q1
$548K Buy
+19,471
New +$556K 0.41% 52
2015
Q4
Sell
-10,857
Closed -$324K 638
2015
Q3
$324K Buy
+10,857
New +$348K 0.15% 167
2015
Q1
Sell
-37,575
Closed -$222K 399
2014
Q4
$222K Buy
+37,575
New +$1.08M 0.17% 230

Other funds holding PFE

Boothbay Fund Management's PFE Position: Q1 2026 in Review

Boothbay Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,127 shares — an estimated $302K sold.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and held it in 18 quarters. The position peaked at $72.4M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Boothbay Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 12,127 Pfizer shares in Q1 2026, an estimated $302K.
  • Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and held it in 18 quarters.
  • Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.